Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2013

Oct 11, 2013

34129_dirs_2013-10-11_f28bc3e1-bce2-4136-a72a-9f0b67bcde77.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2013-10-09

Reporting Person: Stein Kathryn E (Senior VP, Prd Dev & Reg Aff)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-10-09 Stock Option (right to buy) $16.00 A 10653 Acquired 2023-10-09 Common Stock (10653) Direct

Footnotes

F1: 12.5% of the option becomes exercisable on April 9, 2014 and the remaining 87.5% vests in 14 substantially equal quarterly installments thereafter.